Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Eros Int'l. Files For IPO Of Up To $250 Mln - Quick Facts

Eros International Plc (EROS.L) filed for an initial public offering of its stock Friday with the U.S. Securities and Exchange Commission, with the proposed maximum offering price of $250 million. The company intends plans to list on the New York Stock Exchange under the ticker, "EROS."

Also, the company plans to use the net proceeds from this offering to fund new co-productions and acquisitions, including catalog content, to grow our digital and other distribution channels and for general corporate purposes. The offering is being made through Deutsche Bank Securities, BofA Merrill Lynch, Citigroup, and UBS Investment Bank.

Click here to receive FREE breaking news email alerts for Eros International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
With energy prices showing a significant increase amid rising gasoline prices, the Labor Department released a report on Tuesday showing that U.S. consumer prices rose in line with economist estimates in the month of June. Stocks are likely to move back to the upside in early trading on Tuesday after ending the previous session modestly lower. The major index futures are currently pointing to a higher open for the markets, with the Dow futures up by 55 points. Use of traditional telephony services in the European Union is decreasing as Internet (VoIP) services have become increasingly popular, according to a report on state of EU Telecommunications markets. Tuesday, the European Commission published the 2012 - 2013 report on the telecommunications market and regulation in the EU. The majority of European countries have established broadband plans with
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.